Clinical trial
Cemiplimab Survivorship Epidemiology (CASE) Study
NCT03836105 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cemiplimab Survivorship Epidemiology (CASE) Study
- Lead sponsor
- Regeneron Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 27, 2019
- Completion date
- September 29, 2025
- Enrollment
- 287 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.